On a Friday in November 2011, 67-year-old Dave Hwalek noticed blood in his urine, which prompted him to schedule a doctor’s appointment. He remembers watching…| ufhealth.org
The post A new biomarker, KIM-1, may predict outcomes and response in kidney cancer (mentions E2805/ASSURE) appeared first on ECOG-ACRIN Cancer Research Group.| ECOG-ACRIN Cancer Research Group
📄6mins. A male with metastatic kidney cancer saw remarkable results using Fenbendazole after traditional treatments failed. Within months tumors disappeared, showcasing Fenbendazole's potential for advanced renal cell carcinoma.| Fenbendazole resource